IP Verse

Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy

Patent No. EP4338805 (titled "Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin Therapy") was filed by Amarin Pharmaceuticals Ireland on Jun 28, 2013. The application was issued on Jun 4, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DEVA HOLDINGFeb 26, 2026-
ELKINGTON AND FIFEFeb 26, 2026ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4338805

AMARIN PHARMACEUTICALS IRELAND
Application Number
EP24152359A
Filing Date
Jun 28, 2013
Status
Granted And Under Opposition
May 14, 2025
Publication Date
Jun 4, 2025
External Links
Slate, Register , Google Patents